Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1999
09/16/1999WO1999046371A2 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery
09/16/1999WO1999046368A2 Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment
09/16/1999WO1999046367A2 Methods of diagnosis and triage using cell activation measures
09/16/1999WO1999046365A1 Methods and compositions for the selective expansion of gamma/delta t-cells
09/16/1999WO1999046364A1 Vascular endothelial growth factor 2
09/16/1999WO1999046298A2 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
09/16/1999WO1999046296A1 Ecr673: a 7-transmembrane g-protein coupled receptor
09/16/1999WO1999046295A1 A gene homologous to the drosophila b(2)gen gene and putative yeast 26.5kd protein ypr015c
09/16/1999WO1999046293A1 A zinc finger protein derived from hematopoietic cells
09/16/1999WO1999046292A1 A human p18 gene (cbdara04)
09/16/1999WO1999046291A1 A human glia maturation factor (gmf) beta homolog gene (cbfboe11)
09/16/1999WO1999046290A1 A human angiotensin ii/vasopressin receptor (aii/avp) like gene (cbdakd01)
09/16/1999WO1999046289A1 31 human secreted proteins
09/16/1999WO1999046287A1 Secreted proteins and polynucleotides encoding them
09/16/1999WO1999046284A2 Molecules that home to various selected organs or tissues
09/16/1999WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999WO1999046282A1 Plasminogen-related gene b polypeptides
09/16/1999WO1999046281A2 Novel polypeptides and nucleic acids encoding the same
09/16/1999WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS)
09/16/1999WO1999046274A1 Modified factor viii
09/16/1999WO1999045974A1 Protease inhibitors in absorbent articles
09/16/1999WO1999045973A1 Disposable absorbent article having a skin care composition containing an enzyme inhibitor
09/16/1999WO1999045970A1 Multicomponent complex for use with a substrate
09/16/1999WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies
09/16/1999WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes
09/16/1999WO1999045958A1 Cd154 blockade therapy for modulation of immune responses to implanted devices
09/16/1999WO1999045955A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS
09/16/1999WO1999045953A1 Heparin cofactor ii-containing compositions and method for stabilizing the same
09/16/1999WO1999045952A2 Method of preventing the death of retinal neurons and treating ocular diseases
09/16/1999WO1999045951A2 Thy-1 expression in angiogenesis
09/16/1999WO1999045950A2 Methods of suppressing microglial activation
09/16/1999WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11
09/16/1999WO1999045948A1 Reagents for detection and treatment of kaposi's sarcoma
09/16/1999WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
09/16/1999WO1999045946A1 Emulsion preconcentrates comprising a cyclosporin and glycerides
09/16/1999WO1999045945A1 Improved radiation therapy methods
09/16/1999WO1999045944A1 Proapoptotic peptides, dependence polypeptides and methods of use
09/16/1999WO1999045943A1 Enhancement of the pro-fertility action of a molecule involved in sperm-egg binding
09/16/1999WO1999045942A1 Metastatin and hyaluronate binding proteins and methods of use
09/16/1999WO1999045941A1 Peptide compositions and formulations and use of same
09/16/1999WO1999045940A1 Method and composition for lowering low density lipoprotein cholesterol
09/16/1999WO1999045938A1 Thrombin preparation and products and fibrin sealant methods employing same
09/16/1999WO1999045928A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS
09/16/1999WO1999045923A1 Methods of inhibiting bone resorption
09/16/1999WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
09/16/1999WO1999045903A1 Colonic delivery of protein or peptide compositions
09/16/1999WO1999045894A2 Cosmetic compositions
09/16/1999WO1999045869A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999WO1999045777A1 Compositions and methods for treatment of asthma
09/16/1999WO1999045775A1 Compositions and methods for modulating vascularization
09/16/1999WO1999038967A3 Recombinant proteins derived from hgf and msp
09/16/1999WO1999036440A3 Expression of fusion proteins
09/16/1999WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids
09/16/1999WO1999035243A3 Extension of cellular lifespan, methods and reagents
09/16/1999WO1999034823A3 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS
09/16/1999WO1999033979A3 Bone marrow secreted proteins and polynucleotides
09/16/1999WO1999033868A3 Human papillomavirus vaccine
09/16/1999WO1999032625A3 Nucleotide and protein sequence of mammastatin and methods of use
09/16/1999WO1999032621A3 Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof
09/16/1999WO1999031253A3 Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof
09/16/1999WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999WO1999025831A3 Slit polypeptide and method of modulation of robo with ligands
09/16/1999WO1999015666A3 Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
09/16/1999WO1999015657A3 53bp2 complexes
09/16/1999WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/16/1999DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents
09/16/1999DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents
09/16/1999DE19810947A1 Removal of biological contaminants from biological products using anion-exchange membrane
09/16/1999DE19810655A1 Pharmaceutical composition containing cyclosporin A suitable for topical administration for treating disorders of skin, mucosa and eyes
09/16/1999CA2659664A1 Improved radiation therapy methods
09/16/1999CA2588590A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999CA2587736A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
09/16/1999CA2421394A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421388A1 Novel poypeptides and nucleic acids encoding the same
09/16/1999CA2421375A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421372A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421364A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421345A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421333A1 Pro 351 polypeptides and nucleic acids encoding the same
09/16/1999CA2421329A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421322A1 Pro703 polypeptides and nucleic acids encoding the same
09/16/1999CA2421319A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2421315A1 Novel polypeptides and nucleic acids encoding the same
09/16/1999CA2327329A1 Cholesterol recognition sequence
09/16/1999CA2324624A1 Metastatin and hyaluronate binding proteins and methods of use
09/16/1999CA2323631A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999CA2323460A1 Plasminogen-related gene b polypeptides
09/16/1999CA2323448A1 Methods of inhibiting bone resorption
09/16/1999CA2323443A1 Ige antibody production inhibitors and autoimmune diseases inhibitors
09/16/1999CA2323236A1 Human receptor proteins; related reagents and methods
09/16/1999CA2323210A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes
09/16/1999CA2323199A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor
09/16/1999CA2323077A1 Method and composition for lowering low density lipoprotein cholesterol
09/16/1999CA2323074A1 Compositions and methods for the treatment and prevention of metastatic disorders
09/16/1999CA2323070A1 Chitinase chitin-binding fragments
09/16/1999CA2323069A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
09/16/1999CA2323062A1 Colonic delivery of protein or peptide compositions
09/16/1999CA2323016A1 Multicomponent complex for use with a substrate
09/16/1999CA2322839A1 Peptide compositions and formulations and use of same
1 ... 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 ... 3163